Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

How much is mebendazole?
Are there income restrictions for lipitor's patient program?
Dabrafenib and trametinib cost?
Mebendazole ingredients?
When is tenofovir alafenamide patent expiring?

Venlafaxine 37.5 mg used for?

See the DrugPatentWatch profile for Venlafaxine

Venlafaxine (brand name Effexor XR in its extended‑release form) is a serotonin‑norepinephrine reuptake inhibitor (SNRI) that’s prescribed for a variety of mood‑and‑anxiety disorders.
A 37.5 mg dose is usually the starting dose for the extended‑release formulation (the immediate‑release form is typically started at 37.5 mg twice daily).

Primary indications

Condition Typical clinical use
Major Depressive Disorder (MDD) First‑line therapy; often titrated to 75 mg/day (or 150 mg/day if needed).
Generalized Anxiety Disorder (GAD) Effective for chronic worry and somatic symptoms; dose usually increased to 75 mg/day.
Panic Disorder Helps reduce panic attacks and anticipatory anxiety; doses up to 150 mg/day.
Social Anxiety Disorder Used similarly to GAD, especially when medication is preferred over therapy.
Obsessive‑Compulsive Disorder (OCD) Often added to SSRIs if partial response; can be monotherapy at moderate doses.
Post‑Traumatic Stress Disorder (PTSD) Can be used as adjunctive or monotherapy for intrusive thoughts and hyperarousal.
Chronic Pain (neuropathic) Off‑label for neuropathic pain, fibromyalgia, and diabetic peripheral neuropathy; usually higher doses (150 mg/day or more).
Hot Flashes (Menopause) Off‑label, low doses (37.5–75 mg/day) can reduce hot flashes.
Insomnia (when linked to anxiety or depression) Occasionally used to improve sleep quality as part of anxiety or depressive treatment.

Why 37.5 mg?

  • Safety and tolerability: Starting low helps minimize side effects such as nausea, dizziness, insomnia, and sexual dysfunction.
  • Titration: The dose is usually doubled every 1–2 weeks (e.g., 37.5 mg → 75 mg → 112.5 mg → 150 mg) until the therapeutic benefit is achieved or side effects become limiting.
  • Extended‑release: 37.5 mg of XR is equivalent to 75 mg of the immediate‑release formulation, but XR provides smoother plasma levels and better once‑daily compliance.

Important notes

Topic Details
Monitoring Check blood pressure (especially if >50 mg/day), liver function tests, and watch for serotonin syndrome in drug interactions.
Discontinuation Should be tapered gradually to avoid withdrawal symptoms (e.g., dizziness, flu‑like sensations, electric shock‑like sensations).
Pregnancy & Breastfeeding Category C. Use only if benefits outweigh risks; consult a clinician.
Drug interactions Avoid MAOIs, serotonergic drugs (SSRIs, SNRIs, TCAs, certain pain meds), and alcohol.
Contraindications Known hypersensitivity; uncontrolled hypertension; certain heart conditions (e.g., arrhythmias).

Bottom line

A 37.5 mg dose of venlafaxine XR is typically the initial prescription for most patients starting SNRI therapy, especially for depression and anxiety disorders. It’s then stepped up as needed to achieve symptom relief while monitoring for side effects. If you’re wondering whether this dose is right for a specific condition or how it might interact with other meds, talk to your prescriber for personalized guidance.



Other Questions About Venlafaxine :

desvenlafaxine impurity manufacturers in usa Venlafaxine er 225 mg price? Venlafaxine trade names? Venlafaxine japan nhi price? Cost of venlafaxine? Venlafaxine without insurance? Venlafaxine prices?